Presenters & Panelists:
– Ramya Ramaswami – Lasker Clinical Research Scholar, HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, NIH, HHS (Session Co-Chair), “KSHV-associated diseases – KSHV-Associated Diseases Beyond Silos: Clinical Phenotypes and Translational Opportunities”
– David Boutboul, Clinical Immunology Department, INSERM U976 HIPI, Hôpital Saint Louis, Paris, “Accelerating diagnosis and mechanistic insight into KSHV-associated multicentric Castleman disease and Primary Effusion Lymphoma via peripheral blood and effusion–based liquid-phase approaches”
– Kathryn Lurain, The Ohio State University, Comprehensive Cancer Center, Department of Internal Medicine, Division of Hematology, Columbus, USA, “PEL and KSHV-large cell lymphomas”
– Alessia Dalla Pria – Imperial College, Centre for Immunology and Vaccinology, Department of Infectious Diseases, National Centre for HIV Malignancy, United Kingdom (Session Co-Chair), “KSHV-associated diseases and transplants”
Despite substantial advances in KSHV virology, connecting mechanistic insights to the clinical manifestations of KSHV-associated disease remains a major challenge. The clinical landscape has evolved rapidly, with increasingly heterogeneous presentations across immunocompromised and immunocompetent hosts. Translating advances in viral and host biology into meaningful improvements in diagnosis, risk stratification, and therapy remains an unmet need. This session will highlight how current clinical gaps intersect with unanswered questions in virus–host interactions, leading us to identify opportunities for translational research with direct relevance to patient care.